• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CORDIS CORPORATION CATH MB 5F PIG 110CM 6SH; CATHETER, INTRAVASCULAR, DIAGNOSTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CORDIS CORPORATION CATH MB 5F PIG 110CM 6SH; CATHETER, INTRAVASCULAR, DIAGNOSTIC Back to Search Results
Model Number 532598B
Device Problem Detachment of Device or Device Component (2907)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 11/01/2022
Event Type  Injury  
Manufacturer Narrative
A review of the manufacturing documentation associated with lot 18127005 presented no issues during the manufacturing process that can be related to the reported event.Additional information is pending and will be submitted within 30 days upon receipt.
 
Event Description
As reported, a 5f pigtail 110cm 6sh (sideholes) super torque catheter separated most probably up to the last marker spot and all the markers have broken off when removing after using an unknown high-pressure machine at first run.When the broken pigtail tip was looked at the markers have also migrated, and did not dislodge but it was unsure if this was at the time when they were trying to non-cordis snare the tip out or before everything happened.Another unknown catheter was used successfully to complete the procedure.The procedure was completed successfully without patient injury.The device was stored, handled, and prepped per the instructions for use (ifu).There were no anomalies noted when removed from the package.The intended procedure was an endovascular aneurysm repair (evar).The device was not inserted through a stopcock instead of a hemostatic valve.There was no resistance met while advancing the device.The lesion was not calcified nor was there vessel tortuosity or vessel angulation.The device was not used for a chronic total occlusion (total occlusion >3 months).There was no excessive torqueing required.The device was not kinked in the area of separation.The device will not be returned for evaluation.
 
Event Description
As reported, a 5f pigtail 110cm 6sh (sideholes) super torque catheter separated most probably up to the last marker spot and all the markers have broken off when removing after using another company high-pressure machine at first run.When the broken pigtail tip was looked at the markers have also migrated and did not dislodge but it was unsure if this was at the time when they were trying to non-cordis snare the tip out or before everything happened.Another unknown catheter was used successfully to complete the procedure.The procedure was completed successfully without patient injury.The device was stored, handled, and prepped per the instructions for use (ifu).There were no anomalies noted when removed from the package.There was no damage seen on the product before the procedure.The intended procedure was an endovascular aneurysm repair (evar).The device was not inserted through a stopcock instead of a hemostatic valve.There was no resistance met while advancing the device.The lesion was not calcified nor was there vessel tortuosity or vessel angulation.The device was not used for a chronic total occlusion (total occlusion >3 months).There was no excessive torquing required.The device was not kinked in the area of separation.The device will not be returned for evaluation.
 
Manufacturer Narrative
Complaint conclusion: as reported, a 5f pigtail 110cm 6sh (sideholes) super torque catheter separated most probably up to the last marker spot and all the markers have broken off when removing after using another company high-pressure machine at first run.When the broken pigtail tip was looked at the markers have also migrated and did not dislodge but it was unsure if this was at the time when they were trying to non-cordis snare the tip out or before everything happened.Another unknown catheter was used successfully to complete the procedure.The procedure was completed successfully without patient injury.The device was stored, handled, and prepped per the instructions for use (ifu).There were no anomalies noted when removed from the package.There was no damage seen on the product before the procedure.The intended procedure was an endovascular aneurysm repair (evar).The device was not inserted through a stopcock instead of a hemostatic valve.There was no resistance met while advancing the device.The lesion was not calcified nor was there vessel tortuosity or vessel angulation.The device was not used for a chronic total occlusion (total occlusion >3 months).There was no excessive torquing required.The device was not kinked in the area of separation.The product was not returned for analysis.A product history record (phr) review of lot 18127005 revealed no anomalies or non-conformances during the manufacturing and inspection processes that can be associated with the reported event.Without the return of the device the reported ¿catheter (body/shaft)-separated in patient¿ could not be confirmed or further clarified.Procedural factors such as entrapment during an evar procedure may have contributed to the reported event.According to the instructions for use (ifu), although not intended as a mitigation of risk, ¿manipulation of the catheter under excessive friction due to interaction with other devices or while trapped in the vasculature, can lead to stretching or elongation of the catheter.Stretching or elongation of the catheter during endovascular procedures could result in the marker bands moving along the catheter.In extreme cases, marker bands may come off the catheter and dislodge into the vascular system.Avoid entrapment of the catheter between other endovascular devices and the vessel wall.Avoid excessive friction on the catheter; avoid simultaneous introduction of the catheter and aortic graft devices through the same sheath.¿ the use of the super torque mb catheter in procedures where entrapment of the catheter between endovascular devices and the vessel wall may occur, for example endovascular aortic repair (evar) procedures, is contraindicated.Based on the information available and the phr review, there is no indication that the event is related to the device design or manufacturing process.Therefore, no preventative or corrective actions will be taken at this time.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CATH MB 5F PIG 110CM 6SH
Type of Device
CATHETER, INTRAVASCULAR, DIAGNOSTIC
Manufacturer (Section D)
CORDIS CORPORATION
14201 nw 60 avenue
miami lakes FL 33014
Manufacturer (Section G)
CORDIS CORPORATION
14201 nw 60 avenue
miami lakes FL 33014
Manufacturer Contact
karla castro
14201 nw 60 avenue
miami lakes, FL 33014
7863138372
MDR Report Key16000419
MDR Text Key305680522
Report Number9616099-2022-06164
Device Sequence Number1
Product Code DQO
UDI-Device Identifier10705032012034
UDI-Public(01)10705032012034(17)250630(10)18127005
Combination Product (y/n)N
Reporter Country CodeUK
PMA/PMN Number
K915836
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 12/23/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/16/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number532598B
Device Catalogue Number532598B
Device Lot Number18127005
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/20/2022
Date Device Manufactured07/12/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
INDY OTW VASCULAR RETRIEVER SNARE; PHILIPS HIGH-PRESSURE; UNKNOWN HIGH-PRESSURE
Patient Outcome(s) Life Threatening;
-
-